P. Pierce

发表

Evidence for Distinct 5‐Hydroxytryptamine2 Binding Site Subtypes in Cortical Membrane Preparations

S. Peroutka, P. Pierce, 1989, Journal of neurochemistry.

Ring-substituted amphetamine interactions with neurotransmitter receptor binding sites in human cortex

S. Peroutka, P. Pierce, 1988, Neuroscience Letters.

Differential binding of ergot compounds to human versus rat 5-HT2 cortical receptors.

S. Peroutka, P. Pierce, J. Hagen, 1994, Biological signals.

Molecular structural basis of ligand selectivity for 5-HT2 versus 5-HT1C cortical receptors

S. Peroutka, P. Pierce, Joanne Y. Kim, 1992, Naunyn-Schmiedeberg's Archives of Pharmacology.

(R)-(-)-[77Br]4-bromo-2,5-dimethoxyamphetamine labels a novel 5-hydroxytryptamine binding site in brain membranes.

C. Mathis, S. Peroutka, A. Hamik, 1988, Molecular pharmacology.

Antagonist properties of d-LSD at 5-hydroxytryptamine2 receptors.

S. Peroutka, P. Pierce, 1990, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

Halothane Selectively Inhibits Bradykinin-induced Synovial Plasma Extravasation

I. Rampil, J. Levine, B. S. King, 1995, Anesthesiology.

5-hydroxytryptamine receptor subtype messenger RNAs in human dorsal root ganglia: a polymerase chain reaction study

T. Meuser, S. Peroutka, P. Pierce, 1997, Neuroscience.

d-Lysergic acid diethylamide differentially affects the dual actions of 5-hydroxytryptamine on cortical neurons

S. Peroutka, P. Pierce, 1990, Neuropharmacology.

5-Hydroxytryptamine-induced synovial plasma extravasation is mediated via 5-hydroxytryptamine2A receptors on sympathetic efferent terminals.

J. Levine, P. Green, S. Peroutka, 1995, The Journal of pharmacology and experimental therapeutics.

Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex

S. Peroutka, P. Pierce, 2004, Psychopharmacology.

Antagonism of 5-hydroxytryptamine2 receptor-mediated phosphatidylinositol turnover by d-lysergic acid diethylamide.

S. Peroutka, P. Pierce, 1988, The Journal of pharmacology and experimental therapeutics.

Differential interactions of dimethyltryptamine (DMT) with 5-HT1A and 5-HT2 receptors.

S. Peroutka, P. Pierce, A. Deliganis, 1991, Biochemical pharmacology.

5-hydroxytryptamine receptor subtype messenger RNAs in rat peripheral sensory and sympathetic ganglia: A polymerase chain reaction study

J. Levine, S. Peroutka, P. Pierce, 1996, Neuroscience.

Dual Effect of the Serotonin Agonist, Sumatriptan, on Peripheral Neurogenic Inflammation

J. Levine, S. Peroutka, P. Pierce, 1995, Regional Anesthesia & Pain Medicine.

The clinical utility of pharmacological agents that act at serotonin receptors.

Anne W. Schmidt, A. Sleight, S. Peroutka, 1989, The Journal of neuropsychiatry and clinical neurosciences.